• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Physicians don't have the necessary data to provide clear recommendations but they can provide information regarding risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large population-based case control study to compare the incidence of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the cases to ensure accurate case classification and to limit the chance of bias.

The study of the researchers was not without its limitations. Most important, they were unable to separate the effects of the medication from the disorder at hand. That limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to medication use or confounding by comorbidities. Additionally the study did not examine the long-term effects of offspring on their parents.

The study did find that infants whose mothers took ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the best non stimulant adhd medication for adults medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications during early pregnancies may be offset by the greater benefits to both mother and baby from continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, when they are able, assist them in developing strategies to improve coping skills which can reduce the negative impact of her condition on her daily life and relationships.

Medication Interactions

Doctors are increasingly faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with adhd medication pregnancy (Read This method). The majority of these decisions are made without clear and authoritative evidence regardless, so doctors have to weigh their experience from their own experiences, those of other doctors, and what the research suggests about the subject and their own judgments for each patient.

Particularly, the issue of possible risks to the baby can be a challenge. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are conflicting. Furthermore, most studies restrict their analysis to live births, which could undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects However, other studies haven't found a correlation. Most studies show a neutral, or even slightly negative, impact. In the end, a careful risk/benefit analysis must be done in each case.

It isn't easy, but not impossible for women suffering from intuniv adhd medication to stop taking their medication. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for those suffering from the disorder. Additionally, the loss of medication may affect the ability to do jobs and drive safely, which are important aspects of daily life for many people suffering from ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop it due to their pregnancy should educate family members, colleagues, and their friends about the condition, the effects on daily functioning, and the advantages of staying on the current treatment. Educating them can also help the woman feel supported when she is struggling with her decision. Certain medications can pass through the placenta. If a woman decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers used two massive datasets to analyze more than 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher rates of specific heart defects such as ventriculoseptal defect.

The researchers of the study did not find any association between early use of medication and congenital anomalies like facial deformities or club feet. The results are in agreement with previous studies which showed a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of the time of pregnancy. The risk increased in the latter stages of pregnancy when many women began to stop taking their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to undergo caesarean section, low Apgar score after delivery and a baby who needed breathing assistance during birth. However the researchers of the study were unable to eliminate selection bias by restricting the study to women who prescribes adhd medication didn't have other medical issues that could have contributed to these findings.

Researchers hope that their study will help doctors when they encounter pregnant women. The researchers suggest that, while discussing risks and benefits are important, the choice on whether to continue or stop taking medication should be in light of the severity of each woman's ADHD symptoms and her requirements.

The authors warn that, while stopping the medication is an option to consider, it is not advised due to the high prevalence of depression and mental health issues among women who are pregnant or have recently given birth. Further, research shows that women who stop taking their medications will have a harder adjustment to life without them after the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women suffering from ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments and prepare for the birth of their child and adjust to a new routine. Therefore, many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk in low amounts. However, the rate of medication exposure to the newborn can vary depending on dosage, frequency it is taken and the time of day the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn isn't yet fully known.

Because of the lack of research, some physicians may recommend stopping stimulant drugs during a woman's pregnancy. This is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the risks to the embryo. As long as more information is available, GPs can inquire about pregnant patients if they have a history of ADHD or if they plan to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, an increasing number of patients are opting to do so. They have found after consulting with their doctors that the benefits of continuing their current medication far outweigh any possible risks.

Women who suffer from ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non stimulant adhd medications for adults-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also be educated about treatment options and strengthen coping mechanisms. This should include an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of indicators of deterioration, and, if necessary adjustments to the medication regimen.